• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Edwards Lifesciences Edwards INSPIRIS RESILIA Aortic Valve; Heart-Valve, Non-Allograft Tissue

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Edwards Lifesciences Edwards INSPIRIS RESILIA Aortic Valve; Heart-Valve, Non-Allograft Tissue Back to Search Results
Model Number 11500A
Medical Device Problem Codes Adverse Event Without Identified Device or Use Problem (2993); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Endocarditis (1834); Insufficient Information (4580)
Date of Event 06/25/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported through implant patient registry a 23mm 11500a aortic valve implanted two (2) years, six (6) months, was explanted due to unknown reasons.The explanted device was replaced with a 21mm 11500a aortic valve.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional customer complaint.The information reported may or may not be related to the edwards device.
 
Additional Manufacturer Narrative
The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Edwards INSPIRIS RESILIA Aortic Valve
Common Device Name
Heart-Valve, Non-Allograft Tissue
Manufacturer (Section D)
Edwards Lifesciences
1 edwards way
irvine CA 92614
Manufacturer (Section G)
Edwards Lifesciences LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
jason reves
1 edwards way
irvine, CA 92614
+1(949)250-3859
MDR Report Key50107614
Report Number2015691-2026-17355
Device Sequence Number10076620
Product Code LWR
UDI-Device Identifier00690103194982
UDI-Public(01)00690103194982
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P150048
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2026
Reporter Type Manufacturer
Report Source Other,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/18/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number11500A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/07/2026
Supplement Date Received by Manufacturer08/05/2026
Initial Report FDA Received Date07/31/2026
Supplement Report FDA Received Date08/18/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/14/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Required Intervention; Hospitalization;
Patient Age70 YR
Patient SexMale
-
-